Skip to content
EntityQ113254653· pop 9· linked from 618 articles

Nemonaprida

Sign in to save

Also known as (±)-nemonapride, cis-nemonapride, Emilace, rel-5-chloro-2-methoxy-4-(methylamino)-N-[(2R,3R)-2-methyl-1-(phenylmethyl)-3-pyrrolidinyl]benzamide

Nemonapride, also previously known as emonapride and sold under the brand name Emilace, is an atypical antipsychotic which is used in the treatment of schizophrenia. It is taken by mouth.

In the Vinony graph

Within Vinony's link graph, Nemonaprida is referenced by 618 other articles, and connects out to fluphenazine, zuclopenthixol and pipotiazine.

Vinony files it under 5-HT1A agonists, Atypical antipsychotics and Benzamides.

Its subject is documented across 8 Wikipedia language editions.

Research

314 papers

via PubMed

Wikidata facts

Mass
387.171354752
Has use
medication
Show 5 more facts
canonical SMILES
O=C(NC1CCN(CC=2C=CC=CC2)C1C)C=3C=C(Cl)C(=CC3OC)NC
isomeric SMILES
C(N[C@H]1[C@@H](C)N(CC2=CC=CC=C2)CC1)(=O)C3=C(OC)C=C(NC)C(Cl)=C3
subject has role
dopamine antagonist
chemical formula
C₂₁H₂₆ClN₃O₂
Commons category
Nemonapride
Sources (2)

via Wikidata · CC0

Article · Español

Nemonaprida (エミレース, Emilace (JP)) es un antipsicótico atípico aprobado en Japón para el tratamiento de la esquizofrenia. Fue lanzado por Yamanouchi en 1991. La nemonaprida actúa como un antagonista de los receptores D2 y D3 y también es un potente agonista del Receptor 5-HT1A. Tiene afinidad por los receptores sigma.

Abstract from DBpedia / Wikipedia · CC BY-SA

Available in 8 languages

via Wikidata sitelinks · CC0

Connections

Categories